We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$12.1M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$11.5M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.47M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$6.8M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$5.09M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$65.3M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$17.5M
3
PAA icon
Plains All American Pipeline
PAA
+$17.4M
4
AAPL icon
Apple
AAPL
+$15.4M
5
TRGP icon
Targa Resources
TRGP
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RMAX icon
1726
RE/MAX Holdings
RMAX
$260M
$350K ﹤0.01%
8,877
– –
ROAD icon
1727
Construction Partners
ROAD
$6.75B
$349K ﹤0.01%
11,691
– –
CNOB icon
1728
Center Bancorp
CNOB
$1.82B
$349K ﹤0.01%
13,780
-5,291
-28% -$125K
CYBR
1729
DELISTED
CyberArk
CYBR
$349K ﹤0.01%
2,700
– –
AVXL icon
1730
Anavex Life Sciences
AVXL
$301M
$348K ﹤0.01%
23,292
+15,192
+188% +$166K
UVSP icon
1731
Univest Financial
UVSP
$1.19B
$347K ﹤0.01%
12,133
– –
SP
1732
DELISTED
SP Plus Corporation
SP
$346K ﹤0.01%
10,567
– –
EBIX
1733
DELISTED
Ebix Inc
EBIX
$346K ﹤0.01%
10,806
– –
SRDX
1734
DELISTED
Surmodics
SRDX
$345K ﹤0.01%
6,159
– –
SLP icon
1735
Simulations Plus
SLP
$371M
$345K ﹤0.01%
5,451
– –
ATEC icon
1736
Alphatec Holdings
ATEC
$1.49B
$344K ﹤0.01%
21,763
-1,853
-8% -$29.2K
SCHL icon
1737
Scholastic
SCHL
$779M
$343K ﹤0.01%
11,408
-1,982
-15% -$55.8K
SPNT icon
1738
SiriusPoint
SPNT
$2.68B
$343K ﹤0.01%
33,698
+10,025
+42% +$102K
AVIR icon
1739
Atea Pharmaceuticals
AVIR
$417M
$343K ﹤0.01%
5,549
-1,387
-20% -$93.7K
MRSN
1740
DELISTED
Mersana Therapeutics
MRSN
$342K ﹤0.01%
846
-71
-8% -$34.4K
SRI icon
1741
Stoneridge
SRI
$200M
$340K ﹤0.01%
10,678
– –
TCX icon
1742
Tucows
TCX
$137M
$339K ﹤0.01%
4,376
– –
NGM
1743
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$339K ﹤0.01%
11,665
– –
UFCS icon
1744
United Fire Group
UFCS
$1.38B
$337K ﹤0.01%
9,677
– –
HNGR
1745
DELISTED
Hanger Inc.
HNGR
$337K ﹤0.01%
14,755
-2,542
-15% -$58.2K
IBRX icon
1746
ImmunityBio
IBRX
$8.12B
$336K ﹤0.01%
14,151
– –
KROS icon
1747
Keros Therapeutics
KROS
$217M
$336K ﹤0.01%
5,456
– –
AEGN
1748
DELISTED
Aegion Corp
AEGN
$336K ﹤0.01%
11,680
-1,170
-9% -$27.9K
PETQ
1749
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$335K ﹤0.01%
9,493
– –
FMTX
1750
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$335K ﹤0.01%
11,944
+4,910
+70% +$177K
68 69
70
71 72

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.